Aurochem India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 38 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 M
- Revenue Growth 13904.53%
- Profit Growth 14388.77%
- Ebitda -30190.84%
- Net Worth 11512.36%
- Total Assets 10253.91%
About Aurochem India
Aurochem India Private Limited (AIPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 1987 and has a history of 38 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹7.00 M.
Ankit Khanna and Adarsh Khanna serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1987PTC008505
- Company No.
008505
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 1987
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aurochem India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Khanna  | Director | 18-Feb-1987 | Current |
| Adarsh Khanna | Director | 07-Feb-2022 | Current |
Financial Performance of Aurochem India.
Aurochem India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13904.53% increase. The company also saw a substantial improvement in profitability, with a 14388.77% increase in profit. The company's net worth Soared by an impressive increase of 11512.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurochem India?
Unlock access to Aurochem India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aurogen India Private LimitedAnkit Khanna is a mutual person
- Aurokind India Private Limited
Ankit Khanna is a mutual person
- Carbocryp Solutions Private Limited
Ankit Khanna is a mutual person
Charges (Loans)
₹7.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2009 | Canara Bank | ₹7.00 M | Open |
How Many Employees Work at Aurochem India?
Unlock and access historical data on people associated with Aurochem India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurochem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurochem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
